These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 22157187)

  • 1. Prospects and challenges for the use of stem cell technologies to develop novel therapies for Parkinson disease.
    Chinta SJ; Andersen JK
    Cell Cycle; 2011 Dec; 10(24):4179-80. PubMed ID: 22157187
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Translation of Pluripotent Stem Cell Therapies: Challenges and Considerations.
    Desgres M; Menasché P
    Cell Stem Cell; 2019 Nov; 25(5):594-606. PubMed ID: 31703770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human stem cell research and regenerative medicine--present and future.
    Volarevic V; Ljujic B; Stojkovic P; Lukic A; Arsenijevic N; Stojkovic M
    Br Med Bull; 2011; 99():155-68. PubMed ID: 21669982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potentials of human embryonic stem cells in Parkinson's disease.
    Newman MB; Bakay RA
    Neurotherapeutics; 2008 Apr; 5(2):237-51. PubMed ID: 18394566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent stem cell advances: induced pluripotent stem cells for disease modeling and stem cell-based regeneration.
    Yoshida Y; Yamanaka S
    Circulation; 2010 Jul; 122(1):80-7. PubMed ID: 20606130
    [No Abstract]   [Full Text] [Related]  

  • 7. The future of stem cell therapies for Parkinson disease.
    Parmar M; Grealish S; Henchcliffe C
    Nat Rev Neurosci; 2020 Feb; 21(2):103-115. PubMed ID: 31907406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human embryonic stem cell therapies for neurodegenerative diseases.
    Tomaskovic-Crook E; Crook JM
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):440-8. PubMed ID: 21495960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and criteria of embryonic stem and induced pluripotent stem cells for a dopamine replacement therapy.
    Cooper O; Parmar M; Isacson O
    Prog Brain Res; 2012; 200():265-76. PubMed ID: 23195423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging restorative treatments for Parkinson's disease: manipulation and inducement of dopaminergic neurons from adult stem cells.
    Zhao J; Xu Q
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):509-16. PubMed ID: 21495964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cell therapy for Parkinson's disease with induced pluripotent stem cells].
    Morizane A
    Rinsho Shinkeigaku; 2019 Mar; 59(3):119-124. PubMed ID: 30814448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

  • 13. Emerging concepts in neural stem cell research: autologous repair and cell-based disease modelling.
    Koch P; Kokaia Z; Lindvall O; Brüstle O
    Lancet Neurol; 2009 Sep; 8(9):819-29. PubMed ID: 19679274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concise review: Embryonic stem cells versus induced pluripotent stem cells: the game is on.
    Puri MC; Nagy A
    Stem Cells; 2012 Jan; 30(1):10-4. PubMed ID: 22102565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good practice.
    Nature; 2014 Jun; 510(7504):187-8. PubMed ID: 24926498
    [No Abstract]   [Full Text] [Related]  

  • 17. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One Destination.
    Smith MJ; Webber BR; Mohtashami M; Stefanski HE; Zúñiga-Pflücker JC; Blazar BR
    Stem Cells; 2015 Nov; 33(11):3174-80. PubMed ID: 26227158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cells : it looks simple but can looks deceive?
    Lako M; Armstrong L; Stojkovic M
    Stem Cells; 2010 May; 28(5):845-50. PubMed ID: 20235273
    [No Abstract]   [Full Text] [Related]  

  • 20. Survival, differentiation, and migration of bioreactor-expanded human neural precursor cells in a model of Parkinson disease in rats.
    Mukhida K; Baghbaderani BA; Hong M; Lewington M; Phillips T; McLeod M; Sen A; Behie LA; Mendez I
    Neurosurg Focus; 2008; 24(3-4):E8. PubMed ID: 18341411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.